4521 — Kaken Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥142bn
- ¥75bn
- ¥94bn
- 97
- 83
- 51
- 92
Annual cashflow statement for Kaken Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 18,657 | 13,885 | 6,817 | 9,796 | 19,435 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -824 | 2,515 | 1,515 | -287 | 1,290 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5,772 | -5,549 | -1,647 | -9,685 | 6,500 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14,379 | 13,337 | 9,253 | 2,577 | 29,779 |
| Capital Expenditures | -2,286 | -3,257 | -2,206 | -2,167 | -4,392 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 642 | -4,631 | -421 | -3,687 | -15,258 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,644 | -7,888 | -2,627 | -5,854 | -19,650 |
| Financing Cash Flow Items | -1 | -1 | -1 | -1 | 7,764 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -8,752 | -8,129 | -6,990 | -5,658 | -5,369 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,983 | -2,680 | -364 | -8,935 | 4,760 |